Population Genomics Market Report 2026

Population Genomics Market Overview

• Population Genomics market size has reached to $8.44 billion in 2025 • Expected to grow to $16.34 billion in 2030 at a compound annual growth rate (CAGR) of 14.1% • Growth Driver: Rising Demand For Personalized Medicine Driving The Market Growth Due To Increasing Access To Targeted Therapies • Market Trend: Advancements In Library Preparation Technologies Enhancing Efficiency, Accuracy, And Throughput In Genomic Research • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Population Genomics Market?

Population genomics is the field that examines the genetic differences and similarities across entire populations of organisms by analyzing their complete genomes. It investigates how factors like evolution, natural selection, migration, and genetic drift influence the genetic makeup of populations over time. The main product services of population genomics include consumables, instruments, services, and software. Consumables include single-use laboratory items such as reagents, test kits, assay plates, pipette tips, and cartridges that are essential for conducting experiments. It is used for different sample types such as human, animal, plant, and microbial and is applied for pharmacogenomics, disease research, ancestry and evolution, personalized medicine, and others. It is used by several end-users, including academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others.

What Is The Population Genomics Market Growth Forecast?

The population genomics market size is expected to see rapid growth in the next few years. It will grow to $16.34 billion in 2030 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to increasing application of population genomics in personalized medicine, rising investments in global genomics collaborations, expansion of ai-driven genomic interpretation, growing use of genomics in public health planning, increasing adoption of scalable data management systems. Major trends in the forecast period include increasing deployment of large-scale population sequencing projects, rising use of advanced variant annotation tools, growing integration of population genomics with clinical research, expansion of cloud-based genomics platforms, enhanced focus on data standardization.

Global Population Genomics Market Segmentation

1) By Product And Service: Consumables, Instruments, Services, Software 2) By Sample Type: Human, Animal, Plant, Microbial 3) By Application: Pharmacogenomics, Disease Research, Ancestry And Evolution, Personalized Medicine, Other Applications 4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End-Users Subsegments: 1) By Consumables: Reagents, Kits, Probes And Assay Panels, Enzymes, Buffers And Media, Sample Collection And Storage Materials 2) By Instruments: Sequencers, PCR And qPCR Instruments, Microarray Platforms, Sample Preparation And Extraction Instruments, Imaging Systems, Automation And Robotics Systems 3) By Services: Sequencing Services, Genotyping Services, Bioinformatics And Data Analysis Services, Sample Preparation Services, Custom Assay Development 4) By Software: Data Analysis Software, Genome Assembly Software, Variant Calling And Annotation Software, Cloud-Based Genomics Platforms, Laboratory Information Management Systems (LIMS)

What Is The Driver Of The Population Genomics Market?

The rising demand for personalized medicine is expected to propel the growth of the population genomics market going forward. Personalized medicine refers to the tailoring of medical treatments based on an individual’s genetic profile. This demand for personalized medicine is increasing as the decreasing cost of genomic technologies enables broader access to targeted therapies. Population genomics benefits personalized medicine by revealing genetic variations common within specific populations, enabling healthcare providers to customize treatments and medications for greater effectiveness and safety based on an individual’s genetic profile. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA authorized 16 new personalized treatments for rare disease patients in 2023, compared to just six approvals in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the population genomics industry.

Key Players In The Global Population Genomics Market

Major companies operating in the population genomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Regeneron Pharmaceuticals Inc., Eurofins Scientific SE, Illumina Inc., Charles River Laboratories, Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., Takara Bio Inc, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Color Genomics Inc., Helix OpCo LLC, Personalis Inc., Centogene N.V., Genomics England Limited, Veritas Genetics Inc., Genuity Science, Gene by Gene Ltd., Nebula Genomics Inc., Ancestry.com LLC.

Global Population Genomics Market Trends and Insights

Major companies operating in the population genomics market are focusing on developing advanced solutions, such as ultra-high-throughput library preparation kits, to improve sample consistency, streamline large-scale sequencing workflows, and reduce per-sample processing costs. Ultra-high-throughput library preparation kits refer to specialized NGS workflow tools that enable rapid preparation, normalization, and pooling of hundreds to thousands of DNA or RNA samples in a single, scalable process suitable for population-wide genomic studies. For instance, in October 2024, Twist Bioscience Corporation, a US-based biotechnology company, launched FlexPrep, an ultra-high-throughput library preparation kit featuring Normalization by Ligation (NBL) technology that removes the need for upfront sample quantification, early pooling and multiplexing to simplify handling of variable input samples, and a proprietary Twist-developed enzyme that supports high-volume, cost-efficient processing for population genomics NGS applications.

What Are Latest Mergers And Acquisitions In The Population Genomics Market?

In August 2024, Hitachi High-Tech Corporation, a Japan-based manufacturer of electronic and electrical equipment and systems, acquired Nabsys for an undisclosed amount. As a result of the acquisition, Hitachi High-Tech aims to accelerate the adoption of OhmX technology. It is expected to advance research in diagnostics, prognostics, and therapeutics while strengthening the company’s molecular diagnostics business to support efforts against cancer and rare diseases. Nabsys is a US-based company specializing in population genomics.

Regional Outlook

North America was the largest region in the population genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Population Genomics Market?

The population genomics market consists of revenues earned by entities by providing services such as whole genome sequencing, population structure analysis, evolutionary analysis, and variant annotation. The market value includes the value of related goods sold by the service provider or included within the service offering. The population genomics market also includes sales of next-generation sequencers, microarray scanners, imaging systems, and SNP analysis instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Population Genomics Market Report 2026?

The population genomics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the population genomics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.